MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03313cam a22003617i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
17996026 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
KENaKMTC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20231025080555.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
140113s2013 ne ab b 001 0 eng d |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2013444355 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780123919182 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0123919185 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)ocn819717424 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
YDXCP |
| Language of cataloging |
eng |
| Transcribing agency |
DLC |
| Description conventions |
rda |
| Modifying agency |
BTCTA |
| -- |
OCLCQ |
| -- |
IXA |
| -- |
DLC |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
lccopycat |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RM301.3 |
| Item number |
L36 2013 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.7 |
| Edition number |
23 |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
LAM FRANCIS Y.W |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Pharmacogenomics : |
| Remainder of title |
challenges and opportunities in therapeutic implementation / |
| Statement of responsibility, etc |
editors, Yui-Wing Francis Lam, Department of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA, Larisa H. Cavallari, Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, USA. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Amsterdam |
| Name of publisher, distributor, etc |
Academic press |
| Date of publication, distribution, etc |
C2013 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xiv, 496 pages, 2 unnumbered pages : |
| Other physical details |
illustrations (some color), maps ; |
| Dimensions |
25 cm |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 2# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Principles of pharmacogenomics : pharmacokinetic, pharmacodynamic, and clinical implications / Y.W. Francis Lam, Larisa H. Cavallari. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation includes discussions and viewpoints from the academic, regulatory, pharmaceutical, clinical, socio-ethical and economic perspectives. Each chapter presents an overview of the potential or opportunities within the areas discussed and also outlines foreseeable challenges and limitations in moving pharmacogenomics into drug development and direct therapeutic applications. This edited book contains review questions for a more in-depth analysis of the implications of pharmacogenomics and discussion points to generate ideas on best to move the field forward. Clinical pearls and case studies are used to illustrate real-life experiences and both successful and unsuccessful applications. Tables, figures, and annotations are included throughout the book to facilitate understanding and further reference. Multi-contributed book and chapters are written by contributors who are experts in their field. Provides perspectives from those involved in all aspects of pharmacogenomics-including academic, regulatory, economic, industry and medical-to illustrate how all of the pieces fit together and where the challenges may be. Includes case studies of both successful and unsuccessful applications so readers can consider the potential and challenges in moving the science into drug development and direct therapeutic applications. Chapters contain discussion questions and clinical pearls and enable readers to reflect on how to move pharmacogenomics forward and apply these observations and useful tips to their own work and research<br/> |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmacogenomics. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Lam, Y. W. Francis, |
| Relator term |
editor of compilation. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Cavallari, Larisa H., |
| Relator term |
editor of compilation, |
| -- |
author. |
| 700 12 - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Lam, Y. W. Francis. |
| Title of a work |
Principles of pharmacogenomics. |
| 856 42 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Publisher description |
| Uniform Resource Identifier |
<a href="http://www.loc.gov/catdir/enhancements/fy1606/2013444355-d.html">http://www.loc.gov/catdir/enhancements/fy1606/2013444355-d.html</a> |
| 906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
|---|
| a |
7 |
| b |
cbc |
| c |
copycat |
| d |
2 |
| e |
ncip |
| f |
20 |
| g |
y-gencatlg |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
Books |
| Intials |
VKM |
